National Cancer Center Hospital /ID# 226089

Chuo-ku, Tokyo 104-0045

0 studies enrolling now · 1 studies all time

What they study most

Diffuse Large B-Cell Lymphoma

Studies at this site

• A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) — Running, not enrolling